New Product Launches to Drive the Global Human Milk Oligosaccharides (HMO) Market

The global human milk oligosaccharides (HMO) market is anticipated to exhibit significant growth during the forecast market (2020-2026). The rising shift of consumers towards the sedentary lifestyle along with the rising health-related concerns are promoting the market player of the human milk oligosaccharides market to make new product launches that can meet the demand of customers. Human milk oligosaccharide provides sialic acid that makes a major part of the plasma membrane of nerve cells. Over 150 structurally diverse human milk oligosaccharides are available in nature. Moreover, researches are still going on for the development of various structures of human milk oligosaccharides on an artificial basis, for use in the food industry. 

Browse the full report description Global Human Milk Oligosaccharides (HMOs) Market Size, Share & Trends Analysis Report by Application (Infant Formula, Dietary Supplements, Functional Food & Beverage) Forecast Period (2020-2026) at https://www.omrglobal.com/industry-reports/human-milk-oligosaccharides-hmos-market 

However, the infants are found to be the key consumers of the human milk oligosaccharides. The artificially produced human milk oligosaccharides are found to be safe for consumption by infants as well as children and adults. Therefore, the key players of the market are focusing on launching products that are based on infant use.  Nestle S.A., Zuchem, Inc., BASF SE, DuPont de Nemours, Inc., Royal DSM, Elicityl SA, Glycosyn LLC, Gnubiotics Sciences S.A., Inbiose NV, Jennewein Biotechnologie GmbH, and so on are among the key players operating in the global HMO market. The key market players are adopting different strategies such as merger & acquisition, partnership, Strong R&D investment, expansion of product portfolio, and collaboration among others to remain competitive in the market place. New product launches are a core activity adopted by the major market players to thrive in the marketplace.

Recent Developments in the Human Milk Oligosaccharides Market

• In April 2020, Gerber, early childhood nutrition providing subsidiary of Nestle S.A., ha revealed nationwide availability of two first-of-their-kind A2 milk innovations namely Gerber Good Start A2 Infant Formula and Good Start A2 Toddler Drink in the US. Each product contains an exclusive combination of easy-to-digest A2 ?-casein protein – a high-quality protein found in A2 milk – probiotics and prebiotic human milk oligosaccharide designed to offer advanced digestive support to the infant.
• In September 2018, Laboratoires Guigoz had launched its first infant formula containing human milk oligosaccharides namely Proedge Edge Opti Pro in the French market.  With this product launch, the company intends to expand its customer base in the human milk oligosaccharides segment in France.
• In July 2017, Nestlé Spain had unveiled a new infant formula that reproduces two human milk oligosaccharides found in breast milk. The ingredients have been approved by both the European Food Safety Authority and the US Food and Drug Administration (FDA). 

Global Human Milk Oligosaccharides Market Segmentation

By Application

• Infant Formula
• Dietary Supplements
• Functional Food & Beverage

Global Human Milk Oligosaccharides Market – Segment by Region